Data pay play as nuclear voices grow louder

While China's third quarter GDP was a miss in terms of the major economic data point of the day, investors were more attuned to the Chinese consumer and news overnight that Pfizer had started production on its long awaited vaccine while it completes stage three trials. Yes, markets are praying for a vaccine that will provide hope for a return to normal living in 2021. The ASX finished strongly as banks, health stocks and technology helped push the ASX through the 6200 point barrier, the highest it has been since March finishing the day up 1.07% to 6243 points. 

Our top three VODs are:

Data the next frontier for Dubber

An asymmetrical view on uranium

Go buy something

Hosted on Acast. See acast.com/privacy for more information.